|
Estimation of Nitrosamines from Nitrites level
|
|
8
|
1596
|
December 1, 2024
|
|
FY 2025 GDUFA Science and Research Priorities
|
|
0
|
259
|
November 28, 2024
|
|
N-nitroso Tulathromycin
|
|
1
|
119
|
November 19, 2024
|
|
N-Nitroso duloxetine methods from SwissMedic and Taiwan FDA
|
|
0
|
172
|
October 24, 2024
|
|
LC-MS: Practical method for analyzing NDSRIs with single quadrupole
|
|
2
|
380
|
October 16, 2024
|
|
Chloride suppression in nitrite IC analysis
|
|
1
|
174
|
October 3, 2024
|
|
CROs for TGR mutation assay
|
|
8
|
335
|
October 2, 2024
|
|
Determining Low PPB Levels of Nitrite in Polymeric Excipients
|
|
0
|
249
|
September 10, 2024
|
|
N-nitroso-rivaroxaban amide
|
|
6
|
1555
|
August 29, 2024
|
|
Nitrosamine testing on stability samples?
|
|
19
|
1666
|
July 26, 2024
|
|
Exploration and detection of nitrosamine impurity nitroso-STG-19 in sitagliptin tablets and API as well as nitrites in excipients by LC-MS/MS methods -Pub
|
|
0
|
318
|
July 25, 2024
|
|
Stability of resolution solution
|
|
1
|
240
|
July 24, 2024
|
|
Novel LC-MSMS Method including for E&L of packaging materials
|
|
1
|
799
|
July 11, 2024
|
|
Parts per billion of nitrite in microcrystalline cellulose -Pub
|
|
3
|
1112
|
July 3, 2024
|
|
Nitrite in Pharmaceutical Manufacturing Water: Development of an Ultra-Sensitive Analytical Method, Typical Data, and Discussion of Potential Nitrosamine Formation in Drug Substance and Drug Product from Water
|
|
2
|
709
|
June 20, 2024
|
|
Method of Analysis for N nitroso Diclofenac and Quetiapine
|
|
11
|
2037
|
June 14, 2024
|
|
Formic acid-aided sample preparation method for sensitive and simultaneous analysis of eight nitrosamines in poorly-water soluble pharmaceutical drugs using liquid chromatography–ultraviolet detection
|
|
0
|
253
|
June 2, 2024
|
|
Challenges and winning strategies to develop an analytical method for Nitrosamines
|
|
0
|
736
|
May 19, 2024
|
|
Nitrosamine and NDSRIs conventional detection methods and other options
|
|
5
|
535
|
May 16, 2024
|
|
How to justify the absence of NDSRIs in finished product if the custom synthesis of the same NDSRIs is not possible?
|
|
1
|
782
|
May 13, 2024
|
|
Challenges in Confirmatory Testing for Nitrosamines potential presence Identified from Step 1 Risk Assessment
|
|
5
|
730
|
May 8, 2024
|
|
Safeguarding purity under pressure: detecting nitrosamine contamination
|
|
0
|
422
|
April 23, 2024
|
|
Nitroso amines quantification in drugs which are having MDD Value more than 10.0g/Day
|
|
2
|
441
|
March 20, 2024
|
|
🇪🇺 OMCL Network published NDSRIs Analytical Methods
|
|
1
|
1474
|
March 11, 2024
|
|
Simple and Practical Method for the Quantitative High-Sensitivity Analysis of N-Nitroso Duloxetine in Duloxetine Drug Products Utilizing LC-MS/MS
|
|
0
|
779
|
March 9, 2024
|
|
Anybody using Thermal Energy Analysis for Nitrosamine testing?
|
|
6
|
1230
|
February 27, 2024
|
|
GC-ECD as a method of detection for nitrosamines
|
|
0
|
290
|
February 26, 2024
|
|
New Validated LC-MS Method Development and Estimation of Nitrosamine impurities in Canaglifozin -Pub
|
|
0
|
801
|
February 16, 2024
|
|
Testig method for nitroso Ciprofloxacin
|
|
12
|
1544
|
February 16, 2024
|
|
NDSRIs standards (for confirmatory testing or ames/other tests)
|
|
15
|
1400
|
February 14, 2024
|